Manufacturing Digital: Search Results

Amgen to Present at the 30th Annual J.P. Morgan Global Healthcare Conference

THOUSAND OAKS, Calif., Jan. 4, 2012 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 30th Annual J.P. Morgan Global Healthcare Conference at 10:00 a.m. Pacific Time on Monday, Jan. 9, 2012, at the Westin St. Francis in San Francisco,...

Coca-Cola increases commitment to plant-based bottles

Coca-Cola has announced three multi-million dollar partnerships with leading biotech companies in order to develop 100 percent plant-based bottles

PCI Synthesis Completes R&D Expansion

Contact:
Margaret Bonilla
Birnbach Communications
603-548-0693
Email Contact

Nordion Inc. Declares Quarterly Dividend

OTTAWA, Dec. 13, 2011 /PRNewswire/ - The Board of Directors for Nordion Inc. (TSX: NDN) (NYSE: NDZ), a leading provider of products and services to the global health science market, today declared a quarterly dividend of US$0.10 per share...

Nordion Reports Strong Fiscal 2011 Financial Results; Provides Fiscal 2012 Outlook

Fourth quarter segment earnings increase 22% to $27.8 million compared with fiscal 2010 Strong fiscal 2011 annual revenue growth of 23%, with TheraSphere® revenue up 47% year-over-year $71.6 million in cash returned to shareholders during fiscal 2011 by way...

Arteriocyte Takes the Lead in Promoting Building Future Pipeline of Women in STEM Career Fields

CLEVELAND, Dec. 13, 2011 /PRNewswire/ -- Don Brown, CEO of Arteriocyte Cellular Therapies Medical Systems (Arteriocyte) and Terri Sandu, Executive Director of Hard Hatted Women (HHW), are combining efforts to raise awareness of opportunities for women in Science, Technology, Engineering and...

China Direct Industries (NASDAQ: CDII); Magnesium Demand, Indicators and Outlook

Contact
Investorideas.com
800 665 0411
Dvanzant@investorideas.com

Pearl Group Advisors, Inc
954.232.5363
China Direct Industries, Inc.
Richard Galterio or Lillian Wong
Investor Relations
Phone: 1-877-China-57
Email: richard.galterio@cdii.net
lillian.wong@cdii.net

Kraig Biocraft Laboratories Receives New Custom Zinc Finger Configurations for Advanced Fibers Development

Ben Hansel
Hansel Capital
Email Contact
(720) 288-8495

Kraig Biocraft Laboratories to Host Shareholder Conference Call, Regarding Product, Scientific and Commercialization Developments

Contact:
Ben Hansel
Hansel Capital
Email Contact
(720) 288-8495

Micromachining Leader Potomac Photonics Adds New Capabilities

Potomac Photonics responds to increased demand for microhole drilling with new precision laser cutting systems.

Super cities to kick-start UK manufacturing resurgence

Bristol and Glasgow join list of 'super cities' which will drive manufacturing growth in Britain

Dell packaging and Ford car parts to be made of mushrooms

Start-up Ecovative Design is creating fungus-based biodegradable foam components

Scientists develop magnetically-controlled pill

Scientists at Brown University have demonstrated a way to safely control a maneuverable pill and watch as it passes through the gastrointestinal tract. The main problem with oral administration is that pills often do not dissolve at exactly the right site in the gastrointestinal tract where medicine can be absorbed into the bloodstream.

Johnson & Johnson Produces Real Shards o' Glass Product

American biotech firm to buy Chinese biofuel firm

San Francisco-based Biomagnetics Diagnostics Corp, a leader in the development of diagnostic systems and technology for infectious diseases signed a Letter of Intent (LOI) with the Chinese diesel biofuel developer Zhuhai Oil Energy Science and Technology Ltd.

AssayMetrics secures equity investment from Finance Wales

Cardiff-based AssayMetrics has secured investment from commercial funding company, Finance Wales, to develop a plate reader used in compound screening by the biotech and pharmaceutical industries. The early stage business has also received investment from a syndicate of business angels.

SMMT President stresses importance of world-class training

Merger: American firm buys Chinese pharma company

Boston-based pharmaceutical and biotechnology company Charles River Laboratories, announced plans to buy leading Chinese pharmaceutical, biotech and medical device firm WuXi PharmaTech in one of the largest M&

VIA Pharmaceuticals: Restructuring details announced

VIA Pharmaceuticals, Inc., a biotechnology company focused on the development of compounds for the treatment of cardiovascular and metabolic disease, has today announced a strategic restructuring and financing aimed at focusing the company’s resources on research and development related to its pipeline of drug candidates.

GSK to build new UK biotech plant

GlaxoSmithKline will build a new biotech plant in the UK, its CEO Andrew Witty (pictured) has said.

Search Results